| For: | Nayagam JS, Pereira SP, Devlin J, Harrison PM, Joshi D. Controversies in the management of primary sclerosing cholangitis. World J Hepatol 2016; 8(5): 265-272 [PMID: 26925200 DOI: 10.4254/wjh.v8.i5.265] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i5/265.htm |
| Number | Citing Articles |
| 1 |
Jan Best, Stefaan Verhulst, Wing-Kin Syn, Kimberly Lagaisse, Noemi van Hul, Femke Heindryckx, Jan-Peter Sowa, Liesbeth Peeters, Hans Van Vlierberghe, Isabelle A. Leclercq, Ali Canbay, Laurent Dollé, Leo A. van Grunsven, Mirjam M Zegers. Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies. PLOS ONE 2016; 11(9): e0162286 doi: 10.1371/journal.pone.0162286
|
| 2 |
Eleonora Druve Tavares FAGUNDES, Alexandre Rodrigues FERREIRA, Caroline Caldeira HOSKEN, Thaís Costa Nascentes QUEIROZ. PRIMARY SCLEROSING CHOLANGITIS IN CHILDREN AND ADOLESCENTS. Arquivos de Gastroenterologia 2017; 54(4): 286 doi: 10.1590/s0004-2803.201700000-50
|
| 3 |
Elisa Pose, Pau Sancho-Bru, Mar Coll. Experimental Cholestasis Research. Methods in Molecular Biology 2019; 1981: 249 doi: 10.1007/978-1-4939-9420-5_16
|
| 4 |
Eduardo A. Rodriguez, Elizabeth J. Carey, Keith D. Lindor. Emerging treatments for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2017; 11(5): 451 doi: 10.1080/17474124.2017.1293524
|
| 5 |
Gerri Mortimore. Primary sclerosing cholangitis: a pre-malignant condition. Gastrointestinal Nursing 2017; 15(8): 26 doi: 10.12968/gasn.2017.15.8.26
|
| 6 |
Jin-Bo Zhao, Zheng-Hao Wu, Jia-Yun Lin, Gu-Qing Luo, Chi-Hao Zhang, Guang-Bo Wu, Qiang Fan, Xiao-Liang Qi, Hai-Zhong Huo, Ji-Wei Yu, Hong-Jie Li, Lei Zheng, Meng Luo. Evaluation of a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-induced mouse model in a comparative experimental study of portal hypertension. World Journal of Gastroenterology 2026; 32(9): 114207 doi: 10.3748/wjg.v32.i9.114207
Abstract(15) |
Core Tip(15) |
Full Article(HTML)(89)
|
Full Article with Cover (PDF)-65446K(8)
|
Audio-856K(2)
|
Peer-Review Report-203K(6)
|
Answering Reviewers-100K(5)
|
Supplementary Material-73K(8)
|
Full Article (PDF)-64068K(22)
|
Full Article (XML)-153K(6)
|
Times Cited (0)
|
Total Visits (1123)
|
Open
|
| 7 |
Matei Mandea, Dragos M. Oancea, Mihaela C. Ghioca, Speranta M. Iacob, Razvan A. Iacob, Ioana. G. Lupescu, Liliana S. Gheorghe. The Significance of Enzymatic Cholestasis in Inflammatory Bowel Disease Patients for the Diagnosis of Primary Sclerosing Cholangitis—A Retrospective Study. Journal of Clinical Medicine 2025; 14(16): 5915 doi: 10.3390/jcm14165915
|
| 8 |
Massimiliano Cadamuro, Noemi Girardi, Gregory J. Gores, Mario Strazzabosco, Luca Fabris. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00115
|
| 9 |
Jennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor. Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 2016; 1(1): 68 doi: 10.1016/S2468-1253(16)30010-3
|
